6th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe will take place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants are epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting is by invitation only.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
ERS Training Course: Acute respiratory pandemics: how to plan and manage
This practical course will cover outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and will focus around two practical scenarios in which participants will gain experience in managing an acute epidemic.
Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands
In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.
4th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting 2014
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brings together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
Joint ECDC/WHO Regional Office for Europe report 2013
A new influenza surveillance meeting report has been published. The report follows the third annual ECDC/World Health Organization Regional Office for Europe Influenza Surveillance meeting, which took place in Istanbul from 29 to 31 May 2013.
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.
Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of Ireland
Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 - Final Report of National Narcolepsy Study Steering Committee, Department of Health, Ireland
No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in Europe
Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North America (3) following the 2009 influenza pandemic vaccination campaigns.